Click image to enlarge
The
V-PLEX platform offers analytically validated singleplex and multiplex assay kits. Developed under rigorous design control, V-PLEX kits provide accurate and reproducible results with consistency from lot to lot. The V-PLEX Plus Aβ40 Peptide (4G8) Kit enables the measurement of Aβ40 Peptide (4G8) in a single-analyte format. For information on multiplexing Aβ40 Peptide (4G8) with other analytes, please see
V-PLEX Plus Aβ Peptide Panel 1 (4G8) Kit.V-PLEX Plus kits include controls, wash buffer, and plate seals.
Related Key Terms:
Amyloid beta (X-40) peptide, neurodegeneration, APP, amyloid plaques, Alzheimer's disease
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Alzheimer’s Disease
,
Neurobiology/Neurodegeneration
|
|
|
Analyte(s)
|
|
Aβ40 (4G8)
|
|
|
Species
|
|
Human, Mouse, Rat
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO SECTOR S 600MM
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120MM
,
MESO QuickPlex SQ 120
,
MESO SECTOR S 600
|
|
|
Plate Type
|
|
96-well
|
|
|
Capture Antibody
|
|
Mouse Monoclonal
|
|
|
Detection Antibody
|
|
Mouse Monoclonal
|
|
|
LLOD (Sensitivity)
|
|
5.41 pg/mL
|
|
|
Dynamic Range
|
|
5.41 - 6,000 pg/mL
|
|
|
Sample Type
|
|
Rodent Serum, Rodent Plasma, Cell Culture Supernatant, Tissue Homogenate, CSF
|
|
|
Recombinant standards
|
|
Synthetic Aβ peptide
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Gene ID(s)
|
|
351
|
|
|
UniProt ID(s)
|
|
P05067
|
|
|
Schedule B Code
|
|
3822.19.0000
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Neurodegeneration Control 1 (4G8)
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 2 (4G8)
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 3 (4G8)
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
Aβ1-40 Peptide (4G8)
|
≤-70 °C
|
1 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
1 vial
(75 μL)
|
|
|
|
Aβ40 Peptide Plate
|
2-8 °C
|
1 each
(1 each)
|
|
|
|
Diluent Assembly 9 (includes Diluent 35 – 30 mL, Diluent 100 – 50 mL)
|
2-8 °C
|
1 each
(1 each)
|
|
|
|
|
RT
|
1 bottle
(100 mL)
|
|
|
|
|
RT
|
1 bottle
(50 mL)
|
|
|
|
|
2-8 °C
|
1 vial
(40 μL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Neurodegeneration Control 1 (4G8)
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 2 (4G8)
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 3 (4G8)
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
Aβ1-40 Peptide (4G8)
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
1 vial
(375 μL)
|
|
|
|
Aβ40 Peptide Plate
|
2-8 °C
|
5 each
(1 each)
|
|
|
|
Diluent Assembly 10 (includes Diluent 35 – 150 mL, Diluent 100 – 50 mL)
|
2-8 °C
|
1 each
(1 each)
|
|
|
|
|
RT
|
1 bottle
(100 mL)
|
|
|
|
|
RT
|
1 bottle
(50 mL)
|
|
|
|
|
2-8 °C
|
1 vial
(200 μL)
|
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Neurodegeneration Control 1 (4G8)
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 2 (4G8)
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
Neurodegeneration Control 3 (4G8)
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
Aβ1-40 Peptide (4G8)
|
≤-70 °C
|
25 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
5 vial
(375 μL)
|
|
|
|
Aβ40 Peptide Plate
|
2-8 °C
|
25 each
(1 each)
|
|
|
|
Diluent Assembly 10 (includes Diluent 35 – 150 mL, Diluent 100 – 50 mL)
|
2-8 °C
|
5 each
(1 each)
|
|
|
|
|
RT
|
5 bottle
(100 mL)
|
|
|
|
|
RT
|
5 bottle
(50 mL)
|
|
|
|
|
2-8 °C
|
5 vial
(200 μL)
|
|
|
|
Product Inserts
|
|
|
|
Certificate of analysis
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
Lecanemab in Early Alzheimer's Disease
|
|
|
|
|
|
Related Products
|
Product Name
|
Applications |
Species |
Plate Type |
|
V-PLEX Aβ40 Peptide (4G8) Kit
|
|
|
|
Order Details
Catalog No
Size
Price in USD
Qty
Meso Scale Japan 株式会社